Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pittsburgh, PA
SEC filing record 1 source field available
Fiscal year end
31 December
NeuBase Therapeutics, Inc. has filed 670 SEC EDGAR filings since 16 May 2002

SEC filing history

Showing 151-175 of 582 matching filings.

Per page
25
Current page
7
3

OWNERSHIP DOCUMENT

Filing date
25 May 2021
Reporting date
24 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
25 May 2021
Reporting date
24 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
25 May 2021
Reporting date
25 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

8-K

Filing date
20 May 2021
Reporting date
17 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
13 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
12 May 2021
Reporting date
11 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
30 Apr 2021
Reporting date
29 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
27 Apr 2021
Reporting date
21 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
26 Apr 2021
Reporting date
26 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254980

424B5

Filing date
23 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
22 Apr 2021
Reporting date
22 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254980

424B5

Filing date
21 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-254980

EFFECT filing

Filing date
14 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-254980

FORM S-3

Filing date
01 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35963

FORM 8-K

Filing date
26 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82720

AMENDMENT NO. 1

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .